Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study

INTRODUCTION: The dipeptidyl peptidase-4 (DPP-4) enzyme significantly influences carcinogenic pathways in the skin. The objective of this study was to determine whether DPP-4 inhibitors are associated with the incidence of melanoma and nonmelanoma skin cancer, compared with sulfonylureas. RESEARCH D...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Richeek, Yu, Oriana H Y, Platt, Robert W, Azoulay, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Epidemiology/Health services research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649616/
https://www.ncbi.nlm.nih.gov/pubmed/37949470
http://dx.doi.org/10.1136/bmjdrc-2023-003550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649616/
https://www.ncbi.nlm.nih.gov/pubmed/37949470
http://dx.doi.org/10.1136/bmjdrc-2023-003550

Ejemplares similares